Navigation Links
Professor discovers way to slow the growth of malignant melanoma
Date:7/8/2010

New Queen's University research has shown that the growth of melanoma, one of the most deadly forms of skin cancer, can be slowed when a little known gene called MicroRNA 193b is added.

Victor Tron, head of pathology and molecular medicine, focused on miR-193b when he discovered that it was deficient in melanoma tumors and because there were very few studies done about the gene. The miRNA-193b gene is found in people's DNA and was unknown until 10 years ago.

"Our experiment was a bit of a fishing expedition in the beginning. We thought 193b might be important but the fact we got such a tremendous reaction the melanoma really slowed down when we added 193b was really startling," says Dr. Tron, who worked with eight other Queen's researchers. "It's a totally new discovery."

In experiments, increased levels of miR-193b increased in melanoma cells led to lower levels of a well-known protein called cyclin D1, and decreased melanoma cell growth.

Lab experiments with tissue samples proved that miR-193b plays a role in the melanoma process. Further studies will be needed to find out what causes miR-193b levels to go up and down.

"This is the first step in a long road towards finding a melanoma cure," says Professor Tron.

Melanoma is one of the least common forms of skin cancer, yet causes 75 per cent of skin cancer deaths.


'/>"/>

Contact: Michael Onesi
Michael.Onesi@queensu.ca
613-533-6000 x77513
Queen's University
Source:Eurekalert

Page: 1

Related biology news :

1. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
2. LSU professor uses volcanic emissions to study Earths atmospheric past
3. IU professors new textbook uses the best science writing from the New York Times
4. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
5. IEEE touts NJIT professor for expertise in underwater acoustic communication
6. University of Delaware professor wins Powe Award from Oak Ridge Associated Universities
7. K-State professor using NSF award to study the impact of nitrogen deposition on global change
8. 2 professors at UC Riverside receive Guggenheim Fellowships
9. University of Nevada School of Medicine physiology professor earns $1.2 million grant over four years to study motility of internal anal sphincter muscle
10. University of Nevada, Reno, professor receives exclusive American Fisheries Award of Excellence
11. Queens University professors chemistry discovery may revolutionize cooking oil production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: